Integra to test nerve regeneration product:
This article was originally published in Clinica
Executive Summary
Integra LifeSciences plans to begin Phase II clinical trials of its product for peripheral nerve regeneration in September. Consisting of a bioresorbable collagen tube which is sutured to each end of the severed nerve bundle, the device gives the nerves a protective environment and a direction in which to grow. The Plainsboro, New Jersey-based company said that compared with current microsurgical methods its regeneration device offered rapid closure techniques for peripheral nerve repair with fewer scars.